The global human insulin market valued at USD 26.9 Billion in 2026, is projected to reach USD 43.2 Billion by 2032, expanding at a CAGR of 8.20%. Growth is primarily propelled by the rising global prevalence of diabetes, expanding healthcare access in emerging economies, and the growing adoption of recombinant human insulin formulations. https://manjiri0564.livejournal.com/119715.html?newpost=1